SpringWorks Therapeutics, Inc. | Mid-cap | Healthcare
$46.99
0.00%
| SpringWorks Stock Comparison:
SpringWorks vs VertexSpringWorks vs RegeneronSpringWorks vs BridgeBio PharmaSpringWorks vs Blueprint MedicinesSpringWorks vs Bio-TechneSpringWorks vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 49.1M
Gross Profit 45.6M 92.81%
Operating Income -80.5M -164.07%
Net Income -83.2M -169.47%
EPS (Diluted) $-1.11

Balance Sheet Metrics

Total Assets 505.4M
Total Liabilities 88.0M
Shareholders Equity 417.4M
Debt to Equity 0.21

Cash Flow Metrics

Operating Cash Flow -46.4M
Free Cash Flow -68.8M

Revenue & Profitability Trend

SpringWorks Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i191.6M5.4M0035.0M
Cost of Goods Sold i12.6M422.0K00-
Gross Profit i179.0M5.0M00-
Gross Margin % i93.4%92.3%0.0%0.0%0.0%
Operating Expenses
Research & Development i200.5M150.5M146.1M101.7M51.9M
Selling, General & Administrative i256.7M197.6M134.6M71.8M29.5M
Other Operating Expenses i-----
Total Operating Expenses i457.2M348.0M280.7M173.5M81.3M
Operating Income i-278.1M-343.0M-280.7M-173.5M-46.3M
Operating Margin % i-145.2%-6,297.3%0.0%0.0%-132.4%
Non-Operating Items
Interest Income i26.0M22.9M6.1M546.0K1.3M
Interest Expense i-----
Other Non-Operating Income-6.0M-5.0M-2.9M-988.0K-580.0K
Pre-tax Income i-258.1M-325.1M-277.4M-173.9M-45.6M
Income Tax i-----
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-258.1M-325.1M-277.4M-173.9M-45.6M
Net Margin % i-134.7%-5,968.5%0.0%0.0%-130.2%
Key Metrics
EBITDA i-274.7M-341.3M-279.9M-173.0M-46.0M
EPS (Basic) i-$-5.15$-5.21$-3.59$-1.05
EPS (Diluted) i-$-5.15$-5.21$-3.59$-1.05
Basic Shares Outstanding i-63123936532905284849779043300063
Diluted Shares Outstanding i-63123936532905284849779043300063

Income Statement Trend

SpringWorks Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i69.8M176.1M67.5M104.0M147.1M
Short-term Investments i238.2M303.1M524.7M269.5M361.4M
Accounts Receivable i46.2M5.9M0--
Inventory i10.2M3.1M0--
Other Current Assets16.0M12.7M7.5M9.4M4.9M
Total Current Assets i380.5M500.9M599.8M382.9M513.4M
Non-Current Assets
Property, Plant & Equipment i11.3M8.6M4.7M1.0M1.9M
Goodwill i15.6M11.2M0--
Intangible Assets i15.6M11.2M---
Long-term Investments-----
Other Non-Current Assets6.5M4.2M3.2M3.3M2.6M
Total Non-Current Assets i206.8M224.9M30.5M69.6M62.8M
Total Assets i587.3M725.8M630.2M452.5M576.2M
Liabilities
Current Liabilities
Accounts Payable i12.2M7.4M8.0M3.4M1.4M
Short-term Debt i1.7M1.1M483.0K1.2M1.4M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i100.0M78.2M51.0M30.0M17.6M
Non-Current Liabilities
Long-term Debt i6.2M6.0M4.8M129.0K1.4M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities----164.0K
Total Non-Current Liabilities i6.2M21.4M21.0M129.0K1.5M
Total Liabilities i106.2M99.6M72.0M30.1M19.1M
Equity
Common Stock i7.0K7.0K6.0K5.0K5.0K
Retained Earnings i-1.2B-895.0M-569.9M-292.5M-118.6M
Treasury Stock i12.6M4.1M1.3M0-
Other Equity-----
Total Shareholders Equity i481.1M626.2M558.2M422.4M557.1M
Key Metrics
Total Debt i7.9M7.1M5.3M1.3M2.7M
Working Capital i280.5M422.7M548.7M352.9M495.8M

Balance Sheet Composition

SpringWorks Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-258.1M-325.1M-277.4M-173.9M-45.6M
Depreciation & Amortization i3.5M1.7M765.0K490.0K349.0K
Stock-Based Compensation i109.1M94.5M73.0M38.4M10.0M
Working Capital Changes i-71.3M-11.4M22.9M-185.0K-3.2M
Operating Cash Flow i-215.1M-238.6M-179.6M-134.2M-37.4M
Investing Activities
Capital Expenditures i-----
Acquisitions i-8.2M-2.8M-4.2M0-3.5M
Investment Purchases i-285.1M-575.7M-481.0M-305.4M-442.7M
Investment Sales i378.6M620.7M279.8M391.0M28.0M
Investing Cash Flow i85.2M42.1M-205.4M85.6M-418.2M
Financing Activities
Share Repurchases i-8.4M-2.8M-1.3M00
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i-8.4M296.5M338.7M0269.6M
Free Cash Flow i-196.3M-230.2M-171.8M-129.9M-32.8M
Net Change in Cash i-138.3M100.0M-46.3M-48.6M-186.0M

Cash Flow Trend

SpringWorks Key Financial Ratios

Valuation Ratios

Forward P/E -21.96
Price to Book 8.44
Price to Sales 16.12
PEG Ratio -21.96

Profitability Ratios

Profit Margin -115.60%
Operating Margin -164.07%
Return on Equity -51.57%
Return on Assets -28.47%

Financial Health

Current Ratio 4.33
Debt to Equity 1.77
Beta 0.70

Per Share Data

EPS (TTM) $-3.41
Book Value per Share $5.57
Revenue per Share $2.95

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
swtx3.5B-8.44-51.57%-115.60%1.77
Vertex 101.3B28.085.9022.77%31.86%8.89
Regeneron 63.6B15.122.0915.34%31.37%9.04
BridgeBio Pharma 9.6B-17.12-5.2836.76%98.25%-1.04
Blueprint Medicines 8.4B-120.9924.43-47.71%-27.70%208.50
Bio-Techne 7.9B60.873.926.53%10.89%20.99

Financial data is updated regularly. All figures are in the company's reporting currency.